A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Lilly and Novo still dominate the market for weight-loss and diabetes drugs, but the race is heating up in more ways than one.

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

Compounding can include adding extra ingredients, removing ingredients, or using different strengths of ingredients ... in ...

However, it looks like the stock is back on investors’ radar with the latest positive Zepbound data. Let’s understand the company’s strengths and weaknesses to better analyze how to play the ...

Although the GLP-1 drug Zepbound has been shown to be effective in promoting weight loss, availability and price have been barriers to more widespread use by patients. Eli Lilly headquarters ...

In August, Eli Lilly began offering Zepbound vials in 2.5mg and 5mg dosage strengths through its online LillyDirect pharmacy at a discount of 50% or more compared to the list price of other GLP-1 ...